Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

Jorge A. Marrero*, Laura M Kulik, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Michael Messod Abecassis, Lewis R. Roberts, Julie K. Heimbach

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3693 Scopus citations
Original languageEnglish (US)
Pages (from-to)723-750
Number of pages28
JournalHepatology
Volume68
Issue number2
DOIs
StatePublished - Aug 2018

Funding

This Practice Guidance was developed under the direction of the AASLD Practice Guidelines Committee, which approved the scope of the guidance and provided the peer review. Members of the Committee include Joseph Ahn, M.D.; Alfred Sidney Barritt IV, M.D., M.S.C.R.; James R Burton, Jr., M.D.; Udeme Ekong, M.D., M.D.; Michael W. Fried, M.D., FAASLD (Board Liaison); Ruben Hernaez, M.D., M.P.H., Ph.D.; George Ioannou, M.D., FAASLD; Whitney E. Jackson, M.D.; Patricia D. Jones, M.D., M.S.C.R.; Patrick S Kamath, M.D.; David G Koch, M.D.; Raphael B. Merriman, M.D., FACP, FRCPI; Lopa Mishra, M.D., FAASLD, (Board Liaison); David J. Reich, M.D., FACS; Barry Schlansky, M.D., M.P.H.; Amit G. Singal, M.D., M.S.; James R. Spivey, M.D.; Helen S. Te, M.D., FAASLD; and Tram T. Tran, M.D., FAASLD; Elizabeth C. Verna, M.D., M.S.; and Michael Volk, M.D.

ASJC Scopus subject areas

  • Hepatology

Cite this